All Stories

  1. High quality palliative alternative for patients with advanced locoregional (CN3 Stage) penile cancer
  2. Editorial Comment: 68Ga-Prostate-specific membrane antigen (PSMA) positron emission tomography (pet) in prostate cancer: a systematic review and meta-analysis
  3. Prognostic Impact of Loss of SETD2 in Clear Cell Renal Cell Carcinoma
  4. Influence of treatment access on survival of metastatic renal cell carcinoma in brazilian cancer center
  5. Prostate Cancer Screening in Brazil: a single center experience in the public health system
  6. Consensus on Treatment and Follow-Up for Biochemical Recurrence in Castration-Sensitive Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing Countries
  7. Timing of surgery following SARS-CoV-2 infection
  8. Informed consent and a risk‐based approach to oncologic surgery in a cancer center during the COVID‐19 pandemic
  9. Early postoperative outcomes among patients with delayed surgeries after preoperative positive test for SARS‐CoV‐2: A case‐control study from a single institution
  10. Recommendations on robotic-assisted radical prostatectomy: a Brazilian experts’ consensus
  11. Cost-effectiveness analysis of robotic-assisted versus retropubic radical prostatectomy: a single cancer center experience
  12. Evaluation of the clinical use of PET/CT with 68Ga-PSMA for the assessment of biochemical recurrence of low or intermediate-risk prostate cancer
  13. Penile cancer: a Brazilian consensus statement for low- and middle-income countries
  14. Value of preoperative testing for SARS‐CoV‐2 for elective surgeries in a cancer center during the peak of pandemic in Brazil
  15. Small renal masses in Latin-American population: characteristics and prognostic factors for survival, recurrence and metastasis – a multi-institutional study from LARCG database
  16. Consideration in the management of renal cell carcinoma during the COVID-19 Pandemic
  17. Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG)
  18. Immunohistochemical negative expression of ezrin predicts poor prognosis in clear cell renal cell carcinoma
  19. Immunohistochemical expression of renin is a prognostic factor for recurrence in nonmetastatic renal cell carcinoma
  20. Valor pronóstico de la invasión de grasa perirrenal y/o del seno en pacientes con carcinoma de células renales pT3a: estudio de cohorte multicéntrico. Grupo LARCG
  21. Complete metastasectomy in renal cell carcinoma: a propensity-score matched by the International Metastatic RCC Database Consortium prognostic model
  22. Comparative analysis of functional outcomes between two different techniques after 1088 Robotic-Assisted Radical Prostatectomies in a high-volume cancer center: A Clipless approach.
  23. Prognostic value of PD-L1 expression for surgically treated localized renal cell carcinoma: implications for risk stratification and adjuvant therapies
  24. Renal cell cancer treatment: an expert panel recommendation from the Latin American cooperative group-genitourinary and the Latin American renal cancer group: focus on surgery
  25. Loss of BAP1 expression in metastatic tumor tissue is an event of poor prognosis in patients with metastatic clear cell renal cell carcinoma
  26. Solitary Bone Metastasis as the First Presentation of Germ Cell Testicular Cancer Treated with Internal Hemipelvectomy: A Case Report
  27. Assessment of suicidal behavior and factors associated with a diagnosis of prostate cancer
  28. Assessment of Treatment Patterns for Metastatic Renal Cell Carcinoma in Brazil
  29. Expanding morphological and clinical aspects of hereditary leiomyomatosis and renal cell carcinoma (HLRCC): a case report in a patient with unusual morphology and clinical presentation
  30. Prostate Cancer – Local Treatment after Radiorecurrence: HIFU – High-Intensity Focused Ultrasound
  31. Long-term results of the implantation of the AMS 800 artificial sphincter for post-prostatectomy incontinence: a single-center experience
  32. Tissue-based molecular markers in upper tract urothelial carcinoma and their prognostic implications
  33. Focal therapy will be the next step on prostate cancer management? | Opinion: Yes
  34. Tissue Expression of Erythropoietin Predicts Survival Rates in Clear Cell Renal Cell Carcinoma
  35. The fate of some urologic innovations from the last century
  36. The Middle Term
  37. Epidermal growth factor receptor as an adverse survival predictor in squamous cell carcinoma of the penis
  38. Predictive role of Trimprob associated with multiparametric MRI in the diagnosis of prostate cancer
  39. The creation, development and diffusion of the LARCG- latin american renal cancer group
  40. Tumor histologic grade is the most important prognostic factor in patients with penile cancer and clinically negative lymph nodes not submitted to regional lymphadenectomy
  41. Ulceration in bladder cancer associates with extravesical disease, independent of cell cycle, or hypoxia pathways status
  42. Editorial in This Issue
  43. Epithelial-mesenchymal transition (EMT) phenotype at invasion front of squamous cell carcinoma of the penis influences oncological outcomes
  44. American Confederation of Urology (CAU) experience in minimally invasive partial nephrectomy
  45. Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study
  46. Editorial in This Issue
  47. Editorial. In this issue
  48. Editorial In this issue
  49. Editorial in This Issue
  50. Prognostic factors in patients with penile carcinoma and inguinal lymph node metastasis
  51. Pattern of invasion is the most important prognostic factor in patients with penile cancer submitted to lymph node dissection and pathological absence of lymph node metastasis
  52. Penile cancer
  53. Pathologic and imunohistochemical characterization of tumoral inflammatory cell infiltrate in invasive penile squamous cell carcinomas: Fox-P3 expression is an independent predictor of recurrence
  54. Beyond the frontiers
  55. Mutational status of VHL gene and its clinical importance in renal clear cell carcinoma
  56. Supporting prostate cancer focal therapy: a multidisciplinary International Consensus of Experts (“ICE”)
  57. Polybromo-1 (PBRM1), a SWI/SNF complex subunit is a prognostic marker in clear cell renal cell carcinoma
  58. Hyaluronan-mediated motility receptor (RHAMM) immunohistochemical expression and androgen deprivation in normal peritumoral, hyperplasic and neoplastic prostate tissue
  59. Loss of Caspase 7 Expression Is Associated With Poor Prognosis in Renal Cell Carcinoma Clear Cell Subtype
  60. Penile Cancer: the importance of Prevention
  61. Comment on: EGFR mutational status in Brazilian patients with penile carcinoma
  62. Results of preoperative electrical stimulation of pelvic floor muscles in the continence status following radical retropubic prostatectomy
  63. Immunohistochemical expression of CD44s in renal cell carcinoma lacks independent prognostic significance
  64. Sex with Animals (SWA): Behavioral Characteristics and Possible Association with Penile Cancer. A Multicenter Study
  65. The impact of immunohistochemical expression of nitric oxide synthases on clinical and pathological features of renal cell carcinoma
  66. Comparison of the epidemiologic features and patterns of initial care for prostate cancer between public and private institutions: a survey by the Brazilian Society of Urology
  67. Bilateral testicular germ cell tumours: a systematic review
  68. CD133 immunohistochemical expression predicts progression and cancer-related death in renal cell carcinoma
  69. Impact of renal vein invasion and fat invasion in pT3a renal cell carcinoma
  70. Penile Cancer: Epidemiology and Treatment
  71. Epidemiologic characteristics of renal cell carcinoma in Brazil
  72. The Use of the American Society of Anesthesiology Classification as a Prognostic Factor in Patients with Renal Cell Carcinoma
  73. Epidemiologic study on penile cancer in Brazil
  74. Do Proliferating Cell Nuclear Antigen and MIB-1/Ki-67 Have Prognostic Value in Penile Squamous Cell Carcinoma?
  75. Primary Invasive versus Progressive Invasive Transitional Cell Bladder Cancer: Multicentric Study of Overall Survival Rate
  76. Front pattern of invasion in squamous cell carcinoma of the penis: New prognostic factor for predicting risk of lymph node metastases
  77. Double-barreled wet colostomy is a safe option for simultaneous urinary and fecal diversion. Analysis of 56 procedures from a single institution